The impact of the Glucagon-Like Peptide-1 Receptor Agonist Liraglutide on Natriuretic Peptides in Heart Failure Patients with Reduced Ejection Fraction with and without Type 2 Diabetes
Roni Nielsen, Anders Jorsal, Rasmus Stilling Tougaard, Jon Jarløv Rasmussen, Morten Schou, Lars Videbaek, Ida Gustafsson, Jens Faber, Allan Flyvbjerg, Henrik Wiggers, Lise Tarnow, Caroline Kistorp
Udforsk hvilke forskningsemner 'The impact of the Glucagon-Like Peptide-1 Receptor Agonist Liraglutide on Natriuretic Peptides in Heart Failure Patients with Reduced Ejection Fraction with and without Type 2 Diabetes' indeholder.